As of 2026-03-17, the EV/EBITDA ratio of Biosynex SA (ALBIO.PA) is -13.29. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. ALBIO.PA's latest enterprise value is 72.98 mil EUR. ALBIO.PA's TTM EBITDA according to its financial statements is -5.49 mil EUR. Dividing these 2 quantities gives us the above ALBIO.PA EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 5.6x - 10.1x | 7.8x |
| Forward P/E multiples | 5.8x - 11.0x | 8.4x |
| Fair Price | (4.75) - (6.00) | (5.42) |
| Upside | -658.5% - -805.9% | -737.9% |
| Date | EV/EBITDA |
| 2026-03-13 | -13.30 |
| 2026-03-12 | -13.34 |
| 2026-03-11 | -13.34 |
| 2026-03-10 | -13.34 |
| 2026-03-09 | -13.34 |
| 2026-03-06 | -13.42 |
| 2026-03-05 | -13.36 |
| 2026-03-04 | -13.36 |
| 2026-03-03 | -13.29 |
| 2026-03-02 | -13.56 |
| 2026-02-27 | -13.57 |
| 2026-02-26 | -13.60 |
| 2026-02-25 | -13.69 |
| 2026-02-24 | -13.67 |
| 2026-02-23 | -13.73 |
| 2026-02-20 | -13.76 |
| 2026-02-19 | -13.73 |
| 2026-02-18 | -13.54 |
| 2026-02-17 | -13.80 |
| 2026-02-16 | -13.85 |
| 2026-02-13 | -13.90 |
| 2026-02-12 | -13.87 |
| 2026-02-11 | -13.83 |
| 2026-02-10 | -13.94 |
| 2026-02-09 | -13.83 |
| 2026-02-06 | -13.87 |
| 2026-02-05 | -13.56 |
| 2026-02-04 | -13.53 |
| 2026-02-03 | -13.60 |
| 2026-02-02 | -13.65 |
| 2026-01-30 | -13.70 |
| 2026-01-29 | -13.95 |
| 2026-01-28 | -13.63 |
| 2026-01-27 | -13.94 |
| 2026-01-26 | -14.24 |
| 2026-01-23 | -13.39 |
| 2026-01-22 | -12.91 |
| 2026-01-21 | -12.90 |
| 2026-01-20 | -12.93 |
| 2026-01-19 | -12.86 |
| 2026-01-16 | -12.85 |
| 2026-01-15 | -12.88 |
| 2026-01-14 | -12.79 |
| 2026-01-13 | -12.88 |
| 2026-01-12 | -12.71 |
| 2026-01-09 | -12.37 |
| 2026-01-08 | -12.39 |
| 2026-01-07 | -12.41 |
| 2026-01-06 | -12.39 |
| 2026-01-05 | -12.42 |